Does BELIMUMAB Cause Hepatic cancer? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic cancer have been filed in association with BELIMUMAB (BENLYSTA). This represents 0.0% of all adverse event reports for BELIMUMAB.
5
Reports of Hepatic cancer with BELIMUMAB
0.0%
of all BELIMUMAB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Hepatic cancer From BELIMUMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.
Is Hepatic cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Hepatic cancer?
RANITIDINE (17,818)
SORAFENIB (228)
LEDIPASVIR\SOFOSBUVIR (197)
ADALIMUMAB (193)
RIBAVIRIN (190)
VALSARTAN (165)
RIFAXIMIN (151)
SOFOSBUVIR (141)
ETANERCEPT (97)
ENTECAVIR (94)
Which BELIMUMAB Alternatives Have Lower Hepatic cancer Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID